Codexis (CDXS) financial statements

Healthcare · Biotechnology · Market cap $126M

Codexis reported revenue of $70M in fiscal 2025, up 4.1% a year over 9 years.

Net income was -$44M and the operating margin -59.3%, against -17.5% in 2016.

Free cash flow was -$24M.

The diluted share count rose 114% over the period (dilution).

Revenue and free cash flow

Fiscal years, $ billions.

-0.1-0.100.10.10.12016201720182019202020212022202320242025RevenueFree cash flow
Embed this chart

Free to use in articles and newsletters with the source line. Paste this HTML:

Income statement

Fiscal years, from Codexis's 10-K filings with the SEC.

Fiscal year2016201720182019202020212022202320242025
Revenue$49M$50M$61M$68M$69M$105M$139M$70M$59M$70M
Cost of revenue$10M$14M$13M$16M$14M$22M$38M$13M$16M$9M
Gross profit$39M$36M$48M$53M$55M$83M$101M$57M$43M$61M
Research and development$22M$30M$30M$34M$44M$56M$80M$59M$46M$52M
Selling, general and admin$25M$29M$29M$32M$35M$49M$52M$53M$55M$47M
Operating income-$9M-$23M-$11M-$13M-$24M-$23M-$35M-$68M-$59M-$42M
Pre-tax income-$9M-$23M-$11M-$12M-$24M-$21M-$33M-$76M-$65M-$44M
Income tax-$40,000$81,000-$37,000$17,000$339,000$189,000$276,000$69,000$34,000$47,000
Net income-$9M-$23M-$11M-$12M-$24M-$21M-$34M-$76M-$65M-$44M
EPS (diluted)-$0.21-$0.50-$0.21-$0.21-$0.40-$0.33-$0.51-$1.12-$0.89-$0.50
Diluted shares41M46M52M57M59M65M65M68M73M87M
Gross margin80.0%71.4%79.2%77.2%80.1%78.8%72.6%81.7%72.6%86.7%
Operating margin-17.5%-45.9%-18.6%-18.3%-34.6%-21.7%-25.2%-97.0%-98.6%-59.3%
Net margin-17.5%-46.0%-18.0%-17.4%-34.8%-20.3%-24.2%-108.7%-110.0%-62.5%

Balance sheet

Fiscal years, from Codexis's 10-K filings with the SEC.

Fiscal year2016201720182019202020212022202320242025
Cash and short-term investments$12M$7M$32M$90M$149M$117M$114M$65M$73M$78M
Receivables$6M$11M$12M$9M$14M$25M$32M$10M——
Inventory$825,000$1M$589,000$371,000$964,000$1M$2M$3M$2M$2M
Total current assets$27M$45M$68M$114M$184M$162M$163M$93M$99M$97M
Property, plant and equipment$2M$3M$5M$6M$10M$21M$23M$15M$14M$13M
Goodwill$3M$3M$3M$3M$3M$3M$3M$2M$2M$2M
Total assets$36M$54M$79M$149M$222M$246M$250M$137M$149M$148M
Total current liabilities$12M$25M$18M$15M$25M$33M$49M$36M$24M$25M
Long-term debt$0$302,000—————$0$29M$40M
Total liabilities$17M$29M$23M$44M$52M$82M$106M$50M$82M$97M
Shareholders' equity$19M$25M$56M$106M$170M$164M$145M$87M$67M$51M
Net debt-$19M-$31M-$53M-$90M-$149M-$117M-$114M-$65M$10M-$11M

Cash flow

Fiscal years, from Codexis's 10-K filings with the SEC.

Fiscal year2016201720182019202020212022202320242025
Operating cash flow-$2M-$9M-$14M-$13M-$16M-$14M$11M-$53M-$49M-$19M
Capital spending$888,000$985,000$3M$4M$4M$14M$8M$4M$4M$4M
Free cash flow-$3M-$10M-$17M-$16M-$20M-$28M$3M-$57M-$54M-$24M
Stock-based compensation$6M$7M$8M$7M$8M$12M$15M$10M$13M$10M
Net borrowing——————$0$0$30M$10M
Free cash flow margin-5.6%-19.5%-27.8%-23.8%-29.3%-26.8%2.1%-81.3%-90.5%-33.9%
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for CDXS.
Open CDXS in Investingly

Questions

What was Codexis's revenue in 2025?

$70M in fiscal 2025, from its 10-K filing.

How much free cash flow does Codexis generate?

-$24M in fiscal 2025 (operating cash flow minus capital spending).

From Codexis's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.